Rani Therapeutics Holdings, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Rani Therapeutics details its 2024 financial results and provides updates on its RaniPill platform and pipeline programs, including collaborations and preclinical data.
NASDAQ
Rani Therapeutics focuses on key programs, expands manufacturing, and streamlines operations, including a 25% workforce reduction, to support the RaniPill technology platform.